209 related articles for article (PubMed ID: 30073422)
1. Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization.
Sbattella M; Zanichelli A; Ghia P; Gattei V; Suffritti C; Teatini T; Cicardi M; Castelli R
Med Oncol; 2018 Aug; 35(9):118. PubMed ID: 30073422
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency.
Castelli R; Wu MA; Arquati M; Zanichelli A; Suffritti C; Rossi D; Cicardi M
Br J Haematol; 2016 Mar; 172(6):902-8. PubMed ID: 26728240
[TBL] [Abstract][Full Text] [Related]
3. Acquired Angioedema due to C1 Inhibitor Deficiency Preceding Splenic Marginal Zone Lymphoma: Further Insights from Clinical Practice.
Ferriani MPL; Trevisan-Neto O; Costa JS; Melo JML; Moreno AS; Dias MM; Garibaldi PMM; Pereira GC; Chahud F; Traina F; Arruda LK
Int Arch Allergy Immunol; 2020; 181(12):941-946. PubMed ID: 32894844
[TBL] [Abstract][Full Text] [Related]
4. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
[TBL] [Abstract][Full Text] [Related]
5. Acquired angioedema in B cell lymphoproliferative disease: A retrospective case series.
Wonnaparhown A; Stefanovic A; Lugar P; Hostetler HP
Clin Exp Immunol; 2021 Dec; 206(3):378-383. PubMed ID: 34586637
[TBL] [Abstract][Full Text] [Related]
6. Acquired Angioedema due to C1-Inhibitor Deficiency: A Challenging Condition.
Valle SOR; Alonso MLO; Dortas Junior SD; Goudouris ES; de Carvalho ALRB; Capelo AV; Mansour E; Bernardes AF; Leite LFB; Giavina-Bianchi P; Aun MV; Ferriani MPL; Arruda LK; Grumach AS
Int Arch Allergy Immunol; 2022; 183(5):572-577. PubMed ID: 35325890
[TBL] [Abstract][Full Text] [Related]
7. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
Cugno M; Castelli R; Cicardi M
Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
[TBL] [Abstract][Full Text] [Related]
8. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.
Wu MA; Castelli R
Clin Chem Lab Med; 2016 Feb; 54(2):207-14. PubMed ID: 26068904
[TBL] [Abstract][Full Text] [Related]
9. Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate.
Bork K; Staubach-Renz P; Hardt J
Orphanet J Rare Dis; 2019 Mar; 14(1):65. PubMed ID: 30866985
[TBL] [Abstract][Full Text] [Related]
10. Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic Patients.
Sobotkova M; Zachova R; Hakl R; Kuklinek P; Kralickova P; Krcmova I; Hanzlikova J; Vachova M; Bartunkova J
Int Arch Allergy Immunol; 2021; 182(7):642-649. PubMed ID: 33472202
[TBL] [Abstract][Full Text] [Related]
11. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship.
Castelli R; Zanichelli A; Cicardi M; Cugno M
Crit Rev Oncol Hematol; 2013 Sep; 87(3):323-32. PubMed ID: 23490322
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
[TBL] [Abstract][Full Text] [Related]
13. Acquired C1 Inhibitor Deficiency.
Otani IM; Banerji A
Immunol Allergy Clin North Am; 2017 Aug; 37(3):497-511. PubMed ID: 28687105
[TBL] [Abstract][Full Text] [Related]
14. The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema.
Cicardi M; Zanichelli A
Curr Mol Med; 2010 Jun; 10(4):354-60. PubMed ID: 20455857
[TBL] [Abstract][Full Text] [Related]
15. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
Kalmi G; Nguyen Y; Amarger S; Aubineau M; Bibes B; Blanchard-Delaunay C; Boccon-Gibod I; Bouillet L; Coppo P; Dalmas MC; Debord-Peguet S; Defendi F; Demoreuil C; Du-Thanh A; Gayet S; Hadjadj J; Jeandel PY; Launay D; Ly KH; Avoy CM; Niault M; Ollivier Y; Pelletier F; Porneuf M; Roos-Weil D; Fain O; Gobert D
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):212-222. PubMed ID: 37844846
[TBL] [Abstract][Full Text] [Related]
17. Acquired C1-esterase inhibitor deficiency and positive lupus anticoagulant accompanied by splenic marginal zone B-cell lymphoma.
Sugisaki K; Itoh K; Tamaru J
Clin Exp Rheumatol; 2007; 25(4):627-9. PubMed ID: 17888223
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
Castelli R; Zanichelli A; Cugno M
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
[TBL] [Abstract][Full Text] [Related]
19. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
[TBL] [Abstract][Full Text] [Related]
20. Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review.
Shi Y; Wang C
Clin Immunol; 2021 Sep; 230():108819. PubMed ID: 34358691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
